Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Factors Influencing Disease-Free Survival in Cervical Cancer Patients at a Tertiary Care Facility in India

  • By

  • Bajarang Bahadur

  • Sunil Choudhary

  • Deshna Oswal

  • Tej Singh

  • Shraddha Chaurasiya

  • Mayank Singh

  • July 10, 2026

Share

Clinical Scorecard: Factors Influencing Disease-Free Survival in Cervical Cancer Patients at a Tertiary Care Facility in India

At a Glance

CategoryDetail
ConditionCervical Cancer
Key MechanismsTumor burden and locoregional spread influence disease-free survival.
Target PopulationCervical cancer patients in India, particularly those diagnosed at advanced stages.
Care SettingTertiary care center in India

Key Highlights

  • Median follow-up duration was 23.4 months.
  • Significant predictors of poorer DFS include age ≤50 years, tumor size ≥4 cm, and vaginal involvement.
  • Squamous cell carcinoma accounted for 91.8% of cases.
  • DFS showed a sharp decline during early follow-up, indicating higher recurrence risk.

Guideline-Based Recommendations

Diagnosis

  • Utilize clinical and radiological tests to confirm recurrence.

Management

  • Focus on intensive follow-up during the first two years post-treatment.

Monitoring & Follow-up

  • Implement risk-stratified management based on tumor characteristics.

Risks

  • Advanced disease stage and larger tumor size are associated with increased recurrence risk.

Patient & Prescribing Data

Cervical cancer patients diagnosed between 2011 and 2021.

Treatment response evaluated at first follow-up visit, typically within one month after completion of primary treatment.

Clinical Best Practices

  • Encourage early detection and organized screening programs.
  • Tailor follow-up strategies based on individual risk factors.

Related Resources & Content

Original Source(s)

Survival beyond treatment: patterns and determinants of disease-free survival in cervical cancer at a tertiary care center in India

  • by Bajarang Bahadur, Sunil Choudhary, Deshna Oswal, Tej Singh, Shraddha Chaurasiya, Mayank Singh

  • July 10, 2026

Related Content

Cancer Communication in an Era of Fragmented Trust

Genetic Testing in Retinoblastoma: New Applications

Liquid biopsy and molecular profiling are expanding the diagnostic and prognostic role of genetic testing in retinoblastoma.

Coding for Ocular Tumors

Ocular tumor coding can be challenging because ocular oncology often involves evolving lesions, diagnostic uncertainty, and terminology that does not always translate cleanly into ICD-10-CM codes. Understanding how to distinguish benign, malignant, in situ, and uncertain histologic behavior neoplasms is essential for accurate coding, medical necessity, and audit defensibility.